PMC:7396557 / 56994-57117 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T499","span":{"begin":56,"end":64},"obj":"SP_7"},{"id":"T66219","span":{"begin":56,"end":64},"obj":"SP_7"}],"text":"TRQI has been recommended in 12 therapeutic regimens of COVID-19 in China (see detailed information in Tables 1 and 2 )."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T345","span":{"begin":56,"end":64},"obj":"Disease"}],"attributes":[{"id":"A345","pred":"mondo_id","subj":"T345","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"TRQI has been recommended in 12 therapeutic regimens of COVID-19 in China (see detailed information in Tables 1 and 2 )."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T520","span":{"begin":5,"end":8},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"TRQI has been recommended in 12 therapeutic regimens of COVID-19 in China (see detailed information in Tables 1 and 2 )."}

{"project":"LitCovid-sentences","denotations":[{"id":"T426","span":{"begin":0,"end":123},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"TRQI has been recommended in 12 therapeutic regimens of COVID-19 in China (see detailed information in Tables 1 and 2 )."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1601","span":{"begin":56,"end":64},"obj":"Disease"}],"attributes":[{"id":"A1601","pred":"tao:has_database_id","subj":"1601","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"TRQI has been recommended in 12 therapeutic regimens of COVID-19 in China (see detailed information in Tables 1 and 2 )."}